+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Preclinical CRO Market Size, Share & Trends Analysis Report by Services (Bioanalysis & DMPK Studies, Toxicology Testing), by End Use (Biopharmaceutical Companies, Medical Device Companies), and Segment Forecasts, 2020 - 2027

  • ID: 4452023
  • Report
  • March 2020
  • Region: Global
  • 94 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Envigo Corporation
  • Eurofins Scientific
  • ICON Plc.
  • Medpace, Inc.
  • MPI research
  • PRA Health Sciences, Inc
  • MORE
The global preclinical CRO market size is expected to reach USD 7.8 billion by 2027, registering a CAGR of 8.3% over the forecast period. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trend, which is expected to increase the demand for preclinical trials in the future. Whereas rise in number of complex drugs entering clinical trials and increasing R&D expenses are some of the factors responsible for the preclinical Contract Research Organization (CRO) growth. Increasing prices and changes in reimbursement policies are also anticipated to boost the in emerging countries such as India and China.

Increasing number of new entrants in market is anticipated to help the market to grow during the forecast period. Various companies are focusing on research and development of new drugs and therefore are outsourcing these activities to launch efficient CRO services in the market.

Further key findings from the report suggest:
  • Toxicology testing held the largest share in the service segment in 2019 due to increasing trend of outsourcing, especially in emerging countries
  • Bioanalysis is expected to grow with the highest CAGR of 8.8% over the forecast period
  • North America dominates the market with the largest share of 47.5% in 2019 owing to advanced healthcare infrastructure in the region
  • The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to government support in development of outsourcing hubs along with availability of skilled practitioners
  • Some of the key preclinical CRO market players are Envigo Corporation, MPI research, and Eurofins Scientific.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Envigo Corporation
  • Eurofins Scientific
  • ICON Plc.
  • Medpace, Inc.
  • MPI research
  • PRA Health Sciences, Inc
  • MORE
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and end-use scopes to conclude on the market size

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Preclinical CRO Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Suring number of drugs in preclinical phases
3.4.1.2. Economies of production and scale
3.4.1.3. Increasing R&D expenditure
3.4.2. Market Restraint Analysis
3.4.2.1. High labor cost
3.4.2.2. Stringent regulatory policies
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. Preclinical CRO: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Preclinical CRO Market : Segment Analysis, by Services, 2016 - 2027 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Preclinical CRO Market, by services, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Bioanalysis and DMPK studies
4.5.2. Toxicology testing
4.5.3. Others

Chapter 5. Preclinical CRO Market : Segment Analysis, By End-use, 2016 - 2027 (USD Million)
5.1. Definitions & Scope
5.2. End-use market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Preclinical CRO market, by end-use, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Biopharmaceutical companies
5.5.2. Government and academic institutes
5.5.3. Medical device companies

Chapter 6. Preclinical CRO Market : Regional Market Analysis, By Services, 2016 - 2027 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2019 & 2027
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.7.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.8.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.4. Germany
6.8.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.5. U.K.
6.8.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.9. Netherlands
6.8.9.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.9.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.10. Belgium
6.8.10.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.10.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.11. Switzerland
6.8.11.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.11.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.12. Russia
6.8.12.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.12.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.13. Sweden
6.8.13.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.13.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.9.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.4. China
6.9.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.5. Japan
6.9.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.7. Australia
6.9.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.9. Malaysia
6.9.9.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.9.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.10. Indonesia
6.9.11. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.12. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.13. Singapore
6.9.14. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.15. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.16. Philippines
6.9.17. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.18. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.19. Thailand
6.9.20. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.21. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.10.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.4. Brazil
6.10.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.5. Mexico
6.10.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.6. Argentina
6.10.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.7. Colombia
6.10.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.8. Chile
6.10.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11. Middle East and Africa
6.11.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.11.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.4. South Africa
6.11.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.5. Saudi Arabia
6.11.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.6. UAE
6.11.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.7. Israel
6.11.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.8. Egypt
6.11.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)

Chapter 7. Preclinical CRO Market - Competitive Analysis
7.1. Key companies profiled
7.1.1. Envigo Corporation
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. MPI research
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Eurofins Scientific
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. PRA Health Sciences, Inc
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Wuxi AppTec
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Medpace, Inc.
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Pharmaceutical Product Development (PPD), LLC
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. PARAXEL International Corporation
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. ICON Plc.
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Laboratory Corporation of America, Inc.
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Envigo Corporation
  • MPI research
  • Eurofins Scientific
  • PRA Health Sciences, Inc
  • Wuxi AppTec
  • Medpace, Inc.
  • Pharmaceutical Product Development (PPD), LLC
  • PARAXEL International Corporation
  • ICON Plc.
  • Laboratory Corporation of America, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll